BACKGROUND: West Nile virus (WNV) infection is mostly asymptomatic (AS) but 20% of subjects report WNV fever and 1% of patients experience neurologic diseases with higher rates in elderly and immunosuppressed persons. With no treatment and no vaccine to prevent the development of symptomatic (S) infections, it is essential to understand prognostic factors influencing S disease outcome. Host genetic background has been linked to the development of WNV neuroinvasive disease. This study investigates the association between the ABO and D blood group status and WNV disease outcome. STUDY DESIGN AND METHODS: The distribution of blood groups was investigated within a cohort of 374 WNV+ blood donors including 244 AS and 130 S WNV+ blood donors. Logistic regression analyses were used to examine associations between A, B, O, and D blood groups and WNV clinical disease outcome. RESULTS: S WNV+ donors exhibited increased frequencies of blood group A (S 47.6%, AS 36.8%, p = 0.04; odds ratio [OR], 1.56; 95% confidence interval [CI], 1.01-2.40) and D- individuals (S 21.5%, AS 13.1%, p = 0.03; OR, 1.82; 95% CI, 1.04-3.18). CONCLUSION: The findings suggest a genetic susceptibility placing blood group A and D- individuals at risk for the development of S disease outcome after WNV infection.
BACKGROUND:West Nile virus (WNV) infection is mostly asymptomatic (AS) but 20% of subjects report WNV fever and 1% of patients experience neurologic diseases with higher rates in elderly and immunosuppressed persons. With no treatment and no vaccine to prevent the development of symptomatic (S) infections, it is essential to understand prognostic factors influencing S disease outcome. Host genetic background has been linked to the development of WNV neuroinvasive disease. This study investigates the association between the ABO and D blood group status and WNV disease outcome. STUDY DESIGN AND METHODS: The distribution of blood groups was investigated within a cohort of 374 WNV+ blood donors including 244 AS and 130 S WNV+ blood donors. Logistic regression analyses were used to examine associations between A, B, O, and D blood groups and WNV clinical disease outcome. RESULTS: S WNV+ donors exhibited increased frequencies of blood group A (S 47.6%, AS 36.8%, p = 0.04; odds ratio [OR], 1.56; 95% confidence interval [CI], 1.01-2.40) and D- individuals (S 21.5%, AS 13.1%, p = 0.03; OR, 1.82; 95% CI, 1.04-3.18). CONCLUSION: The findings suggest a genetic susceptibility placing blood group A and D- individuals at risk for the development of S disease outcome after WNV infection.
Authors: Yunfeng Cheng; Yufeng Cheng; Gregory Cheng; C H Chui; F Y Lau; Paul K S Chan; Margaret H L Ng; Joseph J Y Sung; Raymond S M Wong Journal: JAMA Date: 2005-03-23 Impact factor: 56.272
Authors: Siripen Kalayanarooj; Robert V Gibbons; David Vaughn; Sharone Green; Ananda Nisalak; Richard G Jarman; Mammen P Mammen; Guey-Chuen Perng Journal: J Infect Dis Date: 2007-02-23 Impact factor: 5.226
Authors: Lori Lai; Tzong-Hae Lee; Leslie Tobler; Li Wen; Ping Shi; Jeff Alexander; Helen Ewing; Michael Busch Journal: Transfusion Date: 2011-08-09 Impact factor: 3.157
Authors: Marion C Lanteri; Michael S Diamond; Jacqueline P Law; Glen M Chew; Shiquan Wu; Heather C Inglis; Derek Wong; Michael P Busch; Philip J Norris; Lishomwa C Ndhlovu Journal: PLoS One Date: 2014-03-18 Impact factor: 3.240
Authors: Wesam A Nasif; Abeer S E Ali; Asim A Khogeer; Mohammed H Mukhtar; Mohamed M NourEldein; Ahmed Y Shebly; Shmukh H Alqahtani; Yahya A Alnashri; Ghidaa E Khouj; Ziyad I Gadah; Mohammad A Althubiti Journal: Saudi Med J Date: 2022-02 Impact factor: 1.422